The Arizona BioIndustry Association announced the leaders and innovators who are moving the Arizona biosciences industry forward faster at the 2011 AZBio Awards on October 13, 2011 in front of a standing room only crowd. Winners include: Dr. Nadja Anderson of the University of Arizona BIO5 Institute, 2011 Michael A. Cusanovich Educator of the Year, SynCardia Systems, Inc., as the 2011 Arizona Bioscience Company of the Year, Dr. Robert Penny of the International Genomics Consortium as Jon W. McGarity Bioscience Leader of the Year , Dr. Jessica Langbaum of the Banner Alzheimer’s Institute as 2011 Arizona Bioscience Researcher of the Year, and Greg Stanton as the winner of the 2011 Public Service Award.Continue reading
Category Archives: Members
AZBIO Member Guest Posts
MSDx Enters Disease Research Field with Introduction of New NK Perforin Kit
MSDx announced today the first of a series of blood testing products that provide novel tools for studying disease processes. Today the company is introducing The NK Cytolytic Competence Assay (Human CD16/Perforin) Flow Cytometry Kit, a Research Use Only (RUO) kit, which has wide-ranging potential for research in multiple sclerosis, rheumatoid arthritis, type 1 diabetes and many other disease areas.Continue reading
2011 AZBio Awards Honorees Announced
The Arizona BioIndustry is Moving Forward Faster in 2011
The Arizona BioIndustry Association has selected finalists and honorees for its annual awards gala to be held at the Sheraton Wild Horse Pass on Oct. 13. Awards to be presented include: 2011 Michael A. Cusanovich Educator of the Year, Fast Lane Company Awards, the Arizona Bioscience Company of the Year, the Jon W. McGarity Bioscience Leader of the Year Award, and the Arizona Bioscience Researcher of the Year Award.
National LambdaRail appoints Crow as head of Chairman’s Advisory Council
September 14, 2011
Patrick Soon-Shiong, chairman and CEO of National LambdaRail, announced the appointment of ASU President Michael M. Crow as head of a new Chairman’s Advisory Council.Aided by a $100 million guarantee from the Chan Soon-Shiong Institute for Advanced Health to upgrade and extend its network to support big science projects, the council will help guide the new mission of National LambdaRail, the 12,000-mile-high-performance communications network linking the nation’s leading research institutions.Continue reading
Regenesis Biomedical takes to the stage at the AdvaMed 2011 MedTech
Regenesis Biomedical to Participate in the AdvaMed 2011 MedTech Conference: Selected to present in the Wound Management category and serve as a panelist on Emerging Growth Companies.
Scottsdale, Arizona, September 5, 2011 — Regenesis Biomedical, Inc., a medical technology company focused on regenerative medicine, announced today that it was selected to present at the AdvaMed 2011 MedTech conference. Regenesis presents in the Wound Management category. The aim of the conference is to connect companies that have an innovative medical technology to parties interested in investing capital, partnering, or initiating strategic alliances.Continue reading
NAU researcher thrust into the maelstrom after 9/11
ERIC BETZ Sun Staff Reporter azdailysun.com | Monday, September 12, 2011
- On the morning of September 11, 2001, Paul Keim was out for a run with his dog on Observatory Mesa, oblivious to the events unfolding along the eastern seaboard.
He was training for a marathon that he would never run.
Within weeks, he would be sitting on the hood of his Toyota on the tarmac at Flagstaff Pulliam Airport when a blonde woman walked off a Gulfstream jet and handed him a package.
“Dr. Keim, this is the anthrax,” she told him. Read more at the Arizona Daily Sun
Intrinsic Bioprobes, Inc. Acquired by Thermo Fisher
Thermo Fisher Scientific Inc., the world leader in serving science, announced on September 1, 2011 that it has enhanced its workflow for biomarker research and diagnostics by acquiring Tempe, Arizona based Intrinsic Bioprobes Inc., a manufacturer of unique immuno-enrichment, sample-preparation tools used in quantitative mass spectrometry. The Intrinsic Bioprobes portfolio enables Thermo Fisher to offer its worldwide life science research and clinical diagnostics customers an enhanced solution for quantitative protein biomarker detection.
Luceome Biotechnologies Receives $1.9 Million in Phase I and Phase II SBIR Funding to Advance its High Throughput Screening Platform
TUCSON, AZ – LUCEOME BIOTECHNOLOGIES a privately held biotechnology company focused on the discovery and development of its innovative proprietary assay platform today announced the award of $1.6 million in grant funding from The National Institutes of Health to further their research in high throughput screening using the KinaseSeeker™ technology. Earlier this year, Luceome was awarded a grant for $287K for research in the area of poly(ADP-ribose) detection.
The FDA When There’s An App For That
There is a lot happening on the medical device front these days around MDDS (Medical Device Data Systems) and the FDA is paying close attention with new regulations, guidance and requests for comment.
With the April 2012 compliance deadline less than 8 months away, AZBio Member John C. Hoffman of QMR is paying close attention too and keeping our community in the loop via the AZBio Resource Network Group on LinkedIn. If you and your team are working in the MDDS space, you’ll want to get connected and join the discussion.
Roche Appoints Mara G. Aspinall President of Ventana Medical Systems, Inc.
TUCSON, Ariz., Aug. 1, 2011 /PRNewswire/ — Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announced today the appointment of Mara Aspinall to the role of President, Ventana Medical Systems, Inc. Aspinall was most recently Founder, President, and CEO of On-Q-ity, a start-up diagnostics company focused on circulating tumor cell technology. Continue reading